US equities
|
NVDA
$235.23
▲+1.89%
MU
$1,077.96
▼-1.77%
TSLA
$372.13
▲+5.09%
SPCX
$157.35
▲+6.27%
SNDK
$1,716.49
▼-3.98%
AMD
$630.00
▲+2.32%
STX
$824.29
▼-12.83%
WDC
$402.88
▼-12.90%
NVDA
$235.23
▲+1.89%
MU
$1,077.96
▼-1.77%
TSLA
$372.13
▲+5.09%
SPCX
$157.35
▲+6.27%
SNDK
$1,716.49
▼-3.98%
AMD
$630.00
▲+2.32%
STX
$824.29
▼-12.83%
WDC
$402.88
▼-12.90%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Endovia Health Sciences, Inc. Common Stock
(NY:
EDVA
)
0.1614
+0.0004 (+0.25%)
Delayed Quote
Updated: 12:52 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Endovia Health Sciences, Inc. Common Stock
Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways
September 22, 2026
From
Endovia Health Sciences
Via
GlobeNewswire
Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline
August 31, 2026
From
Endovia Health Sciences
Via
GlobeNewswire
Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program
August 25, 2026
FDA establishes Investigational New Animal Drug (INAD) File No. 14145, advancing the Company's companion-animal oncology program and marking first milestone under Lupvindol collaboration
From
Endovia Health Sciences
Via
GlobeNewswire